80 FR 28629 - National Committee on Vital and Health Statistics: Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 96 (May 19, 2015)

Page Range		28629-28629
FR Document		2015-12106

Federal Register, Volume 80 Issue 96 (Tuesday, May 19, 2015)

[Federal Register Volume 80, Number 96 (Tuesday, May 19, 2015)]
[Notices]
[Page 28629]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2015-12106]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Committee on Vital and Health Statistics: Meeting

Pursuant to the Federal Advisory Committee Act, the Department of
Health and Human Services (HHS) announces the following advisory
committee meeting.

Name: National Committee on Vital and Health Statistics (NCVHS)
Review Committee, pursuant to Section 1104(i) of the Patient
Protection and Affordable Care Act (ACA).
Time and Date: June 16, 2015, 9:00 a.m.-5:00 p.m. EST; June 17,
2015, 8:00 a.m.-5:15 p.m. EST.
Place: U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention, National Center for Health
Statistics, 3311 Toledo Road, Auditorium B and C, Hyattsville,
Maryland 20782, (301) 458-4524.
Status: Open.
Purpose: The purpose of this hearing is to obtain information
from the health care industry on the currently adopted standards,
operating rules, code sets and identifiers used in administrative
simplification transactions.
The objectives of this hearing are as follows: (1) Review
currently adopted standards, operating rules, code sets and
identifiers used in each of the HIPAA-named administrative
simplification transactions and evaluate the degree to which they
meet current industry business needs; and (2) Identify transactions,
standards, operating rules, code sets and identifiers used in
administrative simplification that require changes, deletions or new
versions in order to meet industry needs.
We invite the public to prepare and submit written testimony on
any and all areas covered by this hearing. We also invite testifiers
to prepare and submit more extensive written testimony, in addition
to the oral testimony they will be providing during the hearing.
Written testimonies should be sent to Marietta Squire, Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Health Statistics, email msquire@cdc.gov.
Background on the Review Committee, including the Review
Committee's Charter can be accessed at http://www.ncvhs.hhs.gov/subcommittees-work-groups/subcommittee-on-standards/review-committee/.
Contact Person for More Information: Debbie M. Jackson, Acting
Executive Secretary, NCVHS, National Center for Health Statistics,
Centers for Disease Control and Prevention, 3311 Toledo Road, Room
2339, Hyattsville, Maryland 20782, telephone (301) 458-4614 or Terri
Deutsch, Centers for Medicare and Medicaid Services, Office of E-
Health Standards and Services, 7500 Security Boulevard, Baltimore,
Maryland 21244, telephone (410) 786-9462. Program information as
well as summaries of meetings and a roster of committee members are
available on the NCVHS home page of the HHS Web site: http://ncvhs.us/, where further information including an agenda will be
posted when available.
Should you require reasonable accommodation, please contact the
CDC Office of Equal Employment Opportunity on (301) 458-4EEO (4336)
as soon as possible.

Dated: May 13, 2015.
James Scanlon,
Deputy Assistant Secretary for Planning and Evaluation Science and Data
Policy, Office of the Assistant Secretary for Planning and Evaluation.
[FR Doc. 2015-12106 Filed 5-18-15; 8:45 am]
BILLING CODE 4151-05-P

Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices 28629

The draft guidance indicates in through Friday, and will be posted to Background on the Review Committee,
section III.C.10 that, to meet the the docket at http:// including the Review Committee’s Charter
conditions of the guidance, outsourcing www.regulations.gov. can be accessed at http://www.ncvhs.hhs.gov/
facilities compounding animal drug subcommittees-work-groups/subcommittee-
VII. Electronic Access on-standards/review-committee/.
from bulk drug substances for office use Contact Person for More Information:
in veterinary practices include on the Persons with access to the Internet
Debbie M. Jackson, Acting Executive
label of any compounded drug these may obtain the draft guidance at either Secretary, NCVHS, National Center for
four statements: http://www.fda.gov/AnimalVeterinary/ Health Statistics, Centers for Disease Control
• ‘‘Not for resale.’’ GuidanceComplianceEnforcement/ and Prevention, 3311 Toledo Road, Room
• ‘‘For use only in [fill in species and GuidanceforIndustry/ucm042450.htm or 2339, Hyattsville, Maryland 20782, telephone
any associated condition or limitation http://www.regulations.gov. (301) 458–4614 or Terri Deutsch, Centers for
listed in Appendix A].’’ Medicare and Medicaid Services, Office of E-
Dated: May 12, 2015.
• ‘‘Compounded by [name of Health Standards and Services, 7500 Security
Leslie Kux, Boulevard, Baltimore, Maryland 21244,
outsourcing facility].’’
• ‘‘Adverse events associated with Associate Commissioner for Policy. telephone (410) 786–9462. Program
this compounded drug should be [FR Doc. 2015–11982 Filed 5–18–15; 8:45 am] information as well as summaries of meetings
and a roster of committee members are
reported to FDA on a Form FDA 1932a.’’ BILLING CODE 4164–01–P
available on the NCVHS home page of the
We tentatively conclude that these HHS Web site:
four label statements are ‘‘public http://ncvhs.us/, where further information
disclosures of information originally DEPARTMENT OF HEALTH AND
including an agenda will be posted when
supplied by the Federal Government to HUMAN SERVICES available.
the recipient for the purpose of Should you require reasonable
National Committee on Vital and Health
disclosure to the public’’ (5 CFR accommodation, please contact the CDC
Statistics: Meeting Office of Equal Employment Opportunity on
1320.3(c)(2)) and are therefore not
subject to review by OMB under the Pursuant to the Federal Advisory (301) 458–4EEO (4336) as soon as possible.
PRA. Thus, the time it would take to Committee Act, the Department of Dated: May 13, 2015.
provide this information is not included Health and Human Services (HHS) James Scanlon,
in the burden estimate reported in table announces the following advisory Deputy Assistant Secretary for Planning and
2. committee meeting. Evaluation Science and Data Policy, Office
This draft guidance also refers to Name: National Committee on Vital and of the Assistant Secretary for Planning and
previously approved collections of Health Statistics (NCVHS) Review Evaluation.
information. A condition set forth in Committee, pursuant to Section 1104(i) of the [FR Doc. 2015–12106 Filed 5–18–15; 8:45 am]
sections III.A.7., III.B.6, and III.C.5 is Patient Protection and Affordable Care Act BILLING CODE 4151–05–P
that any bulk drug substance used is (ACA).
manufactured by an establishment that Time and Date: June 16, 2015, 9:00 a.m.–
is registered under section 510 of the 5:00 p.m. EST; June 17, 2015, 8:00 a.m.–5:15 DEPARTMENT OF HEALTH AND
FD&C Act (including a foreign p.m. EST.
HUMAN SERVICES
Place: U.S. Department of Health and
establishment that is registered under Human Services, Centers for Disease Control
section 360(i) of the FD&C Act) and is Meetings of the Advisory Group on
and Prevention, National Center for Health
accompanied by a valid certificate of Statistics, 3311 Toledo Road, Auditorium B Prevention, Health Promotion, and
analysis. The information collection and C, Hyattsville, Maryland 20782, (301) Integrative and Public Health
related to the disclosure of the 458–4524.
Status: Open. AGENCY: Office of the Surgeon General
certificate of analysis is approved under
Purpose: The purpose of this hearing is to of the United States Public Health
OMB control number 0910–0139.
Before the proposed information obtain information from the health care Service, Office of the Assistant Secretary
collection provisions contained in this industry on the currently adopted standards, for Health, Office of the Secretary,
draft guidance become effective, we will
operating rules, code sets and identifiers Department of Health and Human
used in administrative simplification Services.
publish a notice in the Federal Register transactions.
announcing OMB’s decision to approve, The objectives of this hearing are as ACTION: Notice.
modify, or disapprove the proposed follows: (1) Review currently adopted
information collection provisions. An standards, operating rules, code sets and SUMMARY: In accordance with Section
Agency may not conduct or sponsor, identifiers used in each of the HIPAA-named 10(a) of the Federal Advisory Committee
and a person is not required to respond administrative simplification transactions Act, Public Law 92–463, as amended
to, a collection of information unless it and evaluate the degree to which they meet (5 U.S.C. App.), notice is hereby given
displays a currently valid OMB control
current industry business needs; and (2) that two meetings are scheduled for the
Identify transactions, standards, operating Advisory Group on Prevention, Health
number. rules, code sets and identifiers used in Promotion, and Integrative and Public
VI. Comments administrative simplification that require Health (the ‘‘Advisory Group’’). The
changes, deletions or new versions in order
Interested persons may submit either to meet industry needs. meetings will be open to the public.
electronic comments regarding this draft We invite the public to prepare and submit Information about the Advisory Group
guidance to http://www.regulations.gov written testimony on any and all areas and the agendas for these meetings can
or written comments to the Division of covered by this hearing. We also invite be obtained by accessing the following
testifiers to prepare and submit more Web site: http://
tkelley on DSK3SPTVN1PROD with NOTICES

Dockets Management (see ADDRESSES). It
is only necessary to send one set of extensive written testimony, in addition to www.surgeongeneral.gov/initiatives/
the oral testimony they will be providing prevention/advisorygrp/index.html.
comments. Identify comments with during the hearing. Written testimonies
Docket No. FDA–2015–D–1176. should be sent to Marietta Squire, Committee DATES: The first meeting will be held on
Received comments may be seen in the Management Specialist, Centers for Disease June 11, 2015, from 11:30 a.m. to 2:30
Division of Dockets Management Control and Prevention, National Center for p.m. EST. The second meeting will be
between 9 a.m. and 4 p.m., Monday Health Statistics, email msquire@cdc.gov. held on August 31 from 9:00 a.m. to

VerDate Sep<11>2014 16:53 May 18, 2015 Jkt 235001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM 19MYN1

Document Created: 2015-12-15 15:30:14
Document Modified: 2015-12-15 15:30:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 16, 2015, 9:00 a.m.-5:00 p.m. EST; June 17, 2015, 8:00 a.m.-5:15 p.m. EST.
FR Citation		80 FR 28629